Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index.

Liquid biopsy in the clinical management of hepatocellular carcinoma

von Felden, Johann, Garcia-Lezana, Teresa, Schulze, Kornelius, Losic, Bojan, Villanueva, Augusto · 2020 · Gut

Abstract

With increasing knowledge on molecular tumour information, precision oncology has revolutionised the medical field over the past years. Liquid biopsy entails the analysis of circulating tumour components, such as circulating tumour DNA, tumour cells or tumour-derived extracellular vesicles, and has thus come as a handy tool for personalised medicine in many cancer entities. Clinical applications under investigation include early cancer detection, prediction of treatment response and molecular monitoring of the disease, for example, to comprehend resistance patterns and clonal tumour evolution. In fact, several tests for blood-based mutation profiling are already commercially available and have entered the clinical field. In the context of hepatocellular carcinoma, where access to tissue specimens remains mostly limited to patients with early stage tumours, liquid biopsy approaches might be particularly helpful. A variety of translational liquid biopsy studies have been carried out to address clinical needs, such as early hepatocellular carcinoma detection and prediction of treatment response. To this regard, methylation profiling of circulating tumour DNA has evolved as a promising surveillance tool for early hepatocellular carcinoma detection in populations at risk, which might soon transform the way surveillance programmes are implemented. This review summarises recent developments in the liquid biopsy oncological space and, in more detail, the potential implications in the clinical management of hepatocellular carcinoma. It further outlines technical peculiarities across liquid biopsy technologies, which might be helpful for interpretation by non-experts.

Overview

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2019-320282

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 112 references

Research works printed but not linked: 1

  1. Mandel, 1948, Les acides nucléiques du plasma sanguin chez l'homme, C R Seances Soc Biol Fil, 142, 241

Cited by

See all 157

Metadata

Authors
von Felden, J., Garcia-Lezana, T., Schulze, K., Losic, B., & Villanueva, A.
Affiliations
  • Department of Internal Medicine, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
  • Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York, USA
  • University Medical Center Hamburg-Eppendorf (DE)
  • Icahn School of Medicine at Mount Sinai (US)
  • Tisch Cancer Institute (US)
Venue
Gut
Publisher
BMJ
Published
2020-09-03
Volume
69
Issue
11
Pages
2025-2034
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W3082225831
Cited by
141
References
112
Citations by year
2026: 12 · 2025: 16 · 2024: 23 · 2023: 38 · 2022: 26 · 2021: 23 · 2020: 3
FWCI
2.29
Type
journal article
Language
en
Open access
closed
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Keywords
liquid biopsy, hepatocellular carcinoma, circulating tumor DNA, circulating tumor cells, extracellular vesicles, DNA methylation profiling, early cancer detection, treatment response prediction, precision oncology, tumor surveillance
MeSH terms
Liquid Biopsy, Carcinoma, Hepatocellular, Humans, Liver Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liquid biopsy in the clinical management of hepatocellular carcinoma. https://app.cochat.ai/papers/10.1136/gutjnl-2019-320282
The paper
von Felden, J., Garcia-Lezana, T., Schulze, K., Losic, B., & Villanueva, A. (2020). Liquid biopsy in the clinical management of hepatocellular carcinoma. Gut. https://doi.org/10.1136/gutjnl-2019-320282

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.